Down-Regulation of Autophagy-Related Protein 5 (ATG5) Contributes to the Pathogenesis of Early-Stage Cutaneous Melanoma
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
The role of autophagy in cancer is controversial: Both tumor-suppressing and tumor-promoting functions have been reported. We show that a key regulator of autophagy, autophagy-related protein 5 (ATG5), is often down-regulated in primary melanomas compared to benign nevi, leading to a reduction of basal autophagy as evidenced by a reduced expression of LC3. A follow-up of 158 primary melanoma patients showed that patients with low levels of ATG5 in their tumors had a reduced progression-free survival. In an in vitro model of melanoma tumorigenesis, where the BRAF oncogene was transduced into normal melanocytes, we observed that lowering ATG5 expression promoted proliferation by precluding oncogene-induced senescence. Hence, it appears that down-regulation of ATG5 contributes to tumorigenesis in early-stage cutaneous melanoma, and the expression of ATG5 and LC3 correlates with melanoma diagnosis and prognosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, autophagy is required for some instances of cell-autonomous tumor suppression by senescence (e.g., in oncogene-induced senescence caused by HRAS V12 and BRAF V600E ) 156,157 and cell death (e.g., in the context of ferroptosis) 158 (Figure 3A).”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [157]
In the citing paper
“Atg5 knockdown promotes proliferation, further suggesting that reduced autophagy at the early stages may contribute to tumorigenesis92.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [92]
In the citing paper
“Atg5 expression has also been reported to decrease as melanoma progresses from benign to malignant92.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [92]
In the citing paper
“LC3 has similarly been reported to decrease during melanoma disease progression92.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [92]
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418 · cited 1×
“Macroautophagy (hereafter autophagy) is a highly conserved cellular self-eating process, in which proteins and organelles are sequestered in double-membrane autophagosomes and, subsequently, degraded by lysosomal enzymes (5).”
BackgroundGuidelines for the use and interpretation of assays for monitoring autophagy
Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., et al. (2012) · Autophagy · doi:10.4161/auto.19496 · Cited by 4,330
The landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Levine, B., & Klionsky, D. J. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00099-1 · Cited by 3,678 · cited 1×
“The core process of autophagy is regulated by autophagy-related proteins (ATGs) (10).”
BackgroundInduction of autophagy and inhibition of tumorigenesis by beclin 1
Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., & Levine, B. (1999) · Nature · doi:10.1038/45257 · Cited by 3,347 · cited 1×
“Mice with allelic loss of Beclin 1, whose protein product regulates the initiation of autophagy, are prone to developing cancer (11), and a monoallelic deletion of Beclin 1 has been found in human breast cancer cells (12).”
BackgroundAutophagy in immunity and inflammation
Levine, B., Mizushima, N., & Virgin, H. W. (2011) · Nature · doi:10.1038/nature09782 · Cited by 3,289 · cited 1×
“In addition to this role in stress, autophagy is involved in development and differentiation (6), aging (7), and immunity (8).”
BackgroundPromotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene
Qu, X., Yu, J., Bhagat, G., Furuya, N., Hibshoosh, H., Troxel, A., Rosen, J., Eskelinen, E.-L., Mizushima, N., Ohsumi, Y., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20039 · Cited by 2,311
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Rubinsztein, D. C., Mariño, G., & Kroemer, G. (2011) · Cell · doi:10.1016/j.cell.2011.07.030 · Cited by 2,107 · cited 1×
“In addition to this role in stress, autophagy is involved in development and differentiation (6), aging (7), and immunity (8).”
BackgroundAutophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis
Degenhardt, K., Mathew, R., Beaudoin, B., Bray, K., Anderson, D., Chen, G., Mukherjee, C., Shi, Y., Gélinas, C., Fan, Y., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.06.001 · Cited by 2,011 · cited 1×
“Moreover, autophagy was induced in melanoma cells under conditions of tumor metastasis (35) and hypoxia (36).”
BackgroundHigh frequency of BRAF mutations in nevi
Pollock, P. M., Harper, U. L., Hansen, K. S., Yudt, L. M., Stark, M., Robbins, C. M., Moses, T. Y., Hostetter, G., Wagner, U., Kakareka, J., et al. (2003) · Nature Genetics · doi:10.1038/ng1054 · Cited by 1,730 · cited 1×
“Lowering ATG5 expression prevents oncogene-induced senescence in melanocytes It is believed that mutations in BRAF can be the first step in the formation of a melanocytic tumor (30).”
BackgroundDeconvoluting the context-dependent role for autophagy in cancer
White, E. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3262 · Cited by 1,704 · cited 3×
“On the other hand, autophagy can protect tumor cells that are exposed to anticancer drugs, indicating the potential for inhibition of autophagy in cancer therapy (9).”
BackgroundInfluentialAutophagy in mammalian development and differentiation
Mizushima, N., & Levine, B. (2010) · Nature Cell Biology · doi:10.1038/ncb0910-823 · Cited by 1,555 · cited 1×
“In addition to this role in stress, autophagy is involved in development and differentiation (6), aging (7), and immunity (8).”
BackgroundSaxonov, S., Berg, P., & Brutlag, D. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510310103 · Cited by 1,401 · cited 1×
“Methylation events often occur in promoter regions with rich G/C content, so-called CpG islands (26).”
BackgroundAutophagy-deficient mice develop multiple liver tumors
Takamura, A., Komatsu, M., Hara, T., Sakamoto, A., Kishi, C., Waguri, S., Eishi, Y., Hino, O., Tanaka, K., & Mizushima, N. (2011) · Genes & Development · doi:10.1101/gad.2016211 · Cited by 1,342 · cited 1×
“The results obtained using this in vitro model are supported by recently published work showing that deletion of Atg5 in the liver of mice was followed by the occurrence of spontaneous liver tumors (33).”
ResultCalpain-mediated cleavage of Atg5 switches autophagy to apoptosis
Yousefi, S., Perozzo, R., Schmid, I., Ziemiecki, A., Schaffner, T., Scapozza, L., Brunner, T., & Simon, H.-U. (2006) · Nature Cell Biology · doi:10.1038/ncb1482 · Cited by 1,158
Autophagy mediates the mitotic senescence transition
Young, A. R. J., Narita, M., Ferreira, M., Kirschner, K., Sadaie, M., Darot, J. F. J., Tavaré, S., Arakawa, S., Shimizu, S., Watt, F. M., et al. (2009) · Genes & Development · doi:10.1101/gad.519709 · Cited by 1,078
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
Soengas, M. S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J. G., Gerald, W. L., Lazebnik, Y. A., et al. (2001) · Nature · doi:10.1038/35051606 · Cited by 966 · cited 2×
“Methylation of CpG islands can be reversed by the DNA methyltransferase inhibitor 5-aza-2′-deoxycytidine (5-aza-dC) (25).”
BackgroundAutophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG
Liang, C., Feng, P., Ku, B., Dotan, I., Canaani, D., Oh, B.-H., & Jung, J. U. (2006) · Nature Cell Biology · doi:10.1038/ncb1426 · Cited by 919 · cited 1×
“In addition, ultraviolet radiation resistance–associated gene protein (UVRAG), an interaction partner of Beclin 1 and an inducer of autophagy, suppresses proliferation and tumorigenicity of human colon cancer cells (14).”
BackgroundDebnath, J., Mills, K. R., Collins, N. L., Reginato, M. J., Muthuswamy, S. K., & Brugge, J. S. (2002) · Cell · doi:10.1016/s0092-8674(02)01001-2 · Cited by 763
Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 Phosphorylation
Wang, R. C., Wei, Y., An, Z., Zou, Z., Xiao, G., Bhagat, G., White, M., Reichelt, J., & Levine, B. (2012) · Science · doi:10.1126/science.1225967 · Cited by 728 · cited 1×
“Moreover, Beclin 1 can be phosphorylated by Akt, leading to an inhibition of autophagy (13).”
BackgroundDeregulated Akt3 Activity Promotes Development of Malignant Melanoma
Stahl, J. M., Sharma, A., Cheung, M., Zimmerman, M., Cheng, J. Q., Bosenberg, M. W., Kester, M., Sandirasegarane, L., & Robertson, G. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1399 · Cited by 594 · cited 1×
“Moreover, the phosphatidylinositol 3-kinase (PI3K) pathway can be activated, owing to loss-of-function mutations in the phosphatase and tensin homolog (PTEN) in 5 to 20% of the patients or to increased expression of protein kinase B (PKB/Akt) in up to 60% (4).”
BackgroundInduction of Autophagy during Extracellular Matrix Detachment Promotes Cell Survival
Fung, C., Lock, R., Gao, S., Salas, E., & Debnath, J. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-10-1092 · Cited by 558
A novel assay to study autophagy: regulation of autophagosome vacuole size by amino acid deprivation
Munafó, D. B., & Colombo, M. I. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.20.3619 · Cited by 516
Human skin fibroblasts in vitro differentiate along a terminal cell lineage.
Bayreuther, K., Rodemann, H. P., Hommel, R., Dittmann, K., Albiez, M., & Francz, P. I. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5112 · Cited by 396
Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006
Jemal, A., Saraiya, M., Patel, P., Cherala, S. S., Barnholtz-Sloan, J., Kim, J., Wiggins, C. L., & Wingo, P. A. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.04.032 · Cited by 385 · cited 1×
“Cutaneous melanoma is a common malignancy showing a rapidly increasing incidence among human cancers (1).”
BackgroundWilhelm, S. M., Collier, I. E., Kronberger, A., Eisen, A. Z., Marmer, B. L., Grant, G. A., Bauer, E. A., & Goldberg, G. I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6725 · Cited by 321 · cited 18×
“It also increased LC3-II after starvation of G-361 cells, but not A-375 cells (fig.”
BackgroundInfluentialChaperone-Mediated Autophagy Is Required for Tumor Growth
Kon, M., Kiffin, R., Koga, H., Chapochnick, J., Macian, F., Varticovski, L., & Cuervo, A. M. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003182 · Cited by 261 · cited 1×
“In addition to macroautophagy, chaperone-mediated autophagy can also promote tumor cell proliferation and cancer metastasis in lung cancer xenografts in both mice and melanoma cell lines (20).”
BackgroundPlatz, A., Egyhazi, S., Ringborg, U., & Hansson, J. (2008) · Molecular Oncology · doi:10.1016/j.molonc.2007.12.003 · Cited by 260
Fecher, L. A., Amaravadi, R. K., & Flaherty, K. T. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f5271c · Cited by 249 · cited 1×
“Both mutated BRAF and NRAS result in constitutive activation of the mitogen-activated protein kinase (MAPK) pathway with increased cell proliferation (3).”
BackgroundMa, X.-H., Piao, S., Wang, D., Mcafee, Q. W., Nathanson, K. L., Lum, J. J., Li, L. Z., & Amaravadi, R. K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2372 · Cited by 234
Toll-like Receptor 3 Expressed by Melanoma Cells as a Target for Therapy?
Salaun, B., Lebecque, S., Matikainen, S., Rimoldi, D., & Romero, P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0274 · Cited by 204 · cited 2×
“Melanoma cell lines WM-451-Lu (38), Me-260 (39), A-375 (40), A-2058 (41), SK-Mel 1 (42), SK-Mel 2 (43), and G-361 (41) were derived from surgically excised human primary or metastatic melanoma tissues and have been described previously.”
BackgroundAutophagy Is a Protective Mechanism for Human Melanoma Cells under Acidic Stress
Marino, M. L., Pellegrini, P., Di Lernia, G., Djavaheri-Mergny, M., Brnjic, S., Zhang, X., Hägg, M., Linder, S., Fais, S., Codogno, P., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.339127 · Cited by 184
Extracellular matrix regulation of autophagy
Lock, R., & Debnath, J. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.05.002 · Cited by 160
Inhibition of PI3K-AKT-mTOR Signaling Sensitizes Melanoma Cells to Cisplatin and Temozolomide
Sinnberg, T. W., Lasithiotakis, K. G., Niessner, H., Schittek, B., Flaherty, K. T., Kulms, D., Maczey, E., Campos‐Domínguez, M., Gogel, J., Garbe, C., et al. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.379 · Cited by 144 · cited 2×
“Melanoma cell lines WM-451-Lu (38), Me-260 (39), A-375 (40), A-2058 (41), SK-Mel 1 (42), SK-Mel 2 (43), and G-361 (41) were derived from surgically excised human primary or metastatic melanoma tissues and have been described previously.”
BackgroundBeclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions
Miracco, C., Cevenini, G., Franchi, A., Luzi, P., Cosci, E., Mourmouras, V., Monciatti, I., Mannucci, S., Biagioli, M., Toscano, M., et al. (2010) · Human Pathology · doi:10.1016/j.humpath.2009.09.004 · Cited by 139 · cited 1×
“Previously published work, however, had reported a down-regulation of Beclin 1 in association with melanoma disease progression (37).”
Epigenetic events in malignant melanoma
Rothhammer-Hampl, T., & Bosserhoff, A. (2007) · Pigment Cell Research · doi:10.1111/j.1600-0749.2007.00367.x · Cited by 113 · cited 1×
“In melanoma, 58 genes exhibiting promoter methylation have been identified, many of them correlating with an elevated expression of DNA methyltransferase (24).”
BackgroundEngling, A., Backhaus, R., Stegmayer, C., Zehe, C., Seelenmeyer, C., Kehlenbach, A., Schwappach, B., Wegehingel, S., & Nickel, W. (2002) · Journal of Cell Science · doi:10.1242/jcs.00036 · Cited by 106
Rodriguez, J., Yanez, J., Vicente, V., Alcaraz, M., Benavente-García, O., Castillo, J., Lorente, J., & Lozano, J. A. (2002) · Melanoma Research · doi:10.1097/00008390-200204000-00001 · Cited by 84 · cited 1×
“Cells and cell culture Melanoma cell lines WM-451-Lu (38), Me-260 (39), A-375 (40), A-2058 (41), SK-Mel 1 (42), SK-Mel 2 (43), and G-361 (41) were derived from surgically excised human primary or metastatic melanoma tissues and have been described previously.”
BackgroundHan, C., Sun, B., Wang, W., Cai, W., Lou, D. W., Sun, Y. K., & Zhao, X. (2011) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.223.243 · Cited by 61 · cited 1×
“For example, LC3, a marker of autophagy, is elevated in metastatic tumors exhibiting vasculogenic mimicry, an alternative type of supplementary blood flow (18).”
BackgroundWalker, G. J., Soyer, H. P., Terzian, T., & Box, N. F. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00923.x · Cited by 52 · cited 1×
“vivo model of melanoma carcinogenesis (31), we have investigated the effects of ATG5 suppression in melanocytes overexpressing oncogenic BRAF to mimic an oncogene activation of benign nevi in vivo.”
BackgroundCalcium Phosphate Mediated Gene Transfer into Established Cell Lines
Okayama, H., & Chen, C. (2003) · Humana Press eBooks · doi:10.1385/0-89603-178-0:15 · Cited by 30 · cited 1×
“Trono, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland) with the calcium phosphate transfection method (45).”
MethodZeise, E., Weichenthal, M., Schwarz, T., & Kulms, D. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23420.x · Cited by 27 · cited 14×
“It also increased LC3-II after starvation of G-361 cells, but not A-375 cells (fig.”
BackgroundInfluentialHonokiol produces anti‐neoplastic effects on melanoma cells in vitro
Mannal, P. W., Schneider, J. G., Tangada, A., McDonald, D. E., & McFadden, D. W. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.21936 · Cited by 25 · cited 1×
“Cells and cell culture Melanoma cell lines WM-451-Lu (38), Me-260 (39), A-375 (40), A-2058 (41), SK-Mel 1 (42), SK-Mel 2 (43), and G-361 (41) were derived from surgically excised human primary or metastatic melanoma tissues and have been described previously.”
BackgroundHara, Y., & Nakamura, M. (2012) · European Journal of Dermatology · doi:10.1684/ejd.2011.1562 · Cited by 22 · cited 1×
“Elevated Beclin 1 expression has also been reported in advanced melanoma together with increased levels of LC3 (19).”
Background
Cited by
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Self-citationAutophagy in malignant transformation and cancer progression
Galluzzi, L., Pietrocola, F., Bravo‐San Pedro, J. M., Amaravadi, R. K., Baehrecke, E. H., Cecconi, F., Codogno, P., Debnath, J., Gewirtz, D. A., Karantza, V., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490784 · Cited by 1,182
“Along similar lines, ATG5 is expressed at low levels in primary melanomas as compared to benign nevi, resulting in reduced autophagic proficiency (Liu et al , 2013a), and its absence favors oncogenesis in mice (Takamura et al , 2011).”
InfluentialSelf-citationApoptosis, autophagy, necroptosis, and cancer metastasis
Su, Z., Yang, Z., Xu, Y., Chen, Y., & Yu, Q. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0321-5 · Cited by 1,042
“Mechanically, reducing ATG5 expression may promote cell proliferation by preventing oncogene-induced senescence and may contribute to the progression of early-stage cutaneous melanoma [82].”
BackgroundThe Roles of Autophagy in Cancer
Yun, C. W., & Lee, S. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113466 · Cited by 965
“A decrease in ATG5 expression, a key regulator of autophagy, reduced survival rate in 158 primary melanoma patients, and decreased ATG5 expression promotes cancer-cell proliferation and is associated with the progression of early stage cancer [104].”
BackgroundJiang, P., & Mizushima, N. (2014) · Cell Research · doi:10.1038/cr.2013.161 · Cited by 775
Metadata
- Authors
- Liu, H., He, Z., von Rütte, T., Yousefi, S., Hunger, R. E., & Simon, H.-U.
- Affiliations
- University of Bern (CH)
- Institute of Pharmacology, University of Bern, CH-3010 Bern, Switzerland.
- University Hospital of Bern (CH)
- Corresponding author
- Simon, Hans-Uwe
- ORCID
- Simon, Hans-Uwe
- Venue
- Science Translational Medicine
- Published
- 2013-09-11
- Volume
- 5
- Issue
- 202
- Pages
- 202ra123-202ra123
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2059388879
- Cited by
- 188
- References
- 46
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 8 · 2023: 14 · 2022: 14 · 2021: 26 · 2020: 18 · 2019: 12 · 2018: 16 · 2017: 14 · 2016: 19 · 2015: 15 · 2014: 13 · 2013: 2
- FWCI
- 11.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Keywords
- ATG5, autophagy, cutaneous melanoma, LC3, oncogene-induced senescence, BRAF, melanocyte proliferation, benign nevi, progression-free survival, prognostic factors, carcinogenesis
- MeSH terms
- Autophagy-Related Protein 5, Cutaneous Malignant Melanoma, Autophagy, Humans, Melanocytes, Melanoma, Microtubule-Associated Proteins, Models, Biological, Neoplasm Staging, Nevus, Pigmented, Oncogenes, Promoter Regions, Genetic, Skin Neoplasms, Down-Regulation, Gene Expression Regulation, Neoplastic, Cellular Senescence, Gene Transfer Techniques, DNA Methylation, Cell Line, Tumor, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.